ArticlePeerJ2023

Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.

Linlin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.